The MEDSynth Lab
 
 
 
Organic synthesis
MEDSynth employs state-of-the-art techniques such as parallel chemistry, solid phase and microwave-assisted organic synthesis (MAOs), and classical solution-phase organic synthesis to increase the outputs. The MEDSynth labs are fully equipped for both liquid and solid-phase syntheses.
Specifically :
 
500 mL Reactor-Ready Controlled Lab reactor 
 
Teledyne Isco CombiFlash System
 
UltiMateTM 3000 Semi-Preparative System
ADME & Drug-like properties  
Once the compounds have been synthesized, the ADME facility is responsible for the following profilation:
Analytical Perkin Elmer UHPLC FLEXAR FX-15 Platform
 
MEDSynth Group in the Metaverse environment of Nanome
 
 
In silico studies
MEDSynth group is also able to perform in silico drug design through the use of different devices.